Cardinal Health added to ‘Tactical Outperform’ list at Evercore ISI

Evercore ISI is adding Cardinal Health to the firm’s “Tactical Outperform” list ahead of Q2 EPS from the Healthcare Technology & Distribution group. Despite the Optum contract loss, an FY25 EPS floor of $7.50-plus “should be largely achievable,” says the firm, which has an In Line rating and $105 price target on Cardinal Health shares.